Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site (Q43228776)
Jump to navigation
Jump to search
scientific article published on 4 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site |
scientific article published on 4 December 2009 |
Statements
1 reference
Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site (English)
1 reference
John D Hainsworth
1 reference
David R Spigel
1 reference
Dana S Thompson
1 reference
Patrick B Murphy
1 reference
Cassie M Lane
1 reference
David M Waterhouse
1 reference
Yuval Naot
1 reference
F Anthony Greco
1 reference
4 December 2009
1 reference
1 reference
14
1 reference
12
1 reference
1189-1197
1 reference
Identifiers
1 reference
1 reference